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Abstract We measured perioperative plasma concentra-
tions of brain-derived neurotrophic factor (BDNF), a major
mediator of synaptic plasticity in the central nervous sys-
tem, in males, 30–65 years old, undergoing lumbar or
cervical discotomy. Patients were randomly allocated to a
general anesthetic with propofol induction and maintenance
or with thiopental induction and isoflurane maintenance.
BDNF plasma concentrations were measured before
induction (baseline), 15 min after induction but before start
of surgery, at skin closure, in the post-anesthetic care unit,
and 24 h postoperatively. Data from 26 patients (13 in each
group) were analyzed. At each time point, BDNF plasma
concentrations showed large variability. At baseline,
concentrations were 631 ± 337 (mean ± SD) pg ml-1 in
the propofol group and were 549 ± 512 pg ml-1 in the
thiopental–isoflurane group (P = 0.31). At 15 min, con-
centrations significantly decreased in the propofol group
(247 ± 219 pg ml-1, P = 0.0012 compared with baseline)
but remained unchanged in the thiopental–isoflurane group
(597 ± 471 pg ml-1, P = 0.798 compared with baseline).
At skin closure and in the post-anesthetic care unit, con-
centrations were not different from baseline in both groups.
At 24 h, concentrations significantly decreased below
baseline in both groups (propofol: 232 ± 129 pg ml-1,
P = 0.0015; thiopental–isoflurane: 253 ± 250 pg ml-1,
P = 0.016). In the propofol group, there was a weak but
statistically significant positive correlation (R2 = 0.38,
P = 0.026) between the duration of surgery and BDNF
plasma concentrations at skin closure. These data suggest
that in males undergoing elective minor surgery, BDNF
plasma concentrations show a specific pattern that is influ-
enced by the anesthetic technique and, possibly, by the
duration of surgery.
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Introduction
Brain-derived neurotrophic factor (BDNF), a non-glycos-
ylated secretory polypeptide, is a member of the
neurotrophin family of growth factors. It plays a funda-
mental role in the survival and differentiation of numerous
neuronal subpopulations during development [1], and is
required for the maintenance of neuronal viability in
adulthood [2]. BDNF is a major mediator of short- and
long-term neuronal plasticity in the adult central nervous
system (CNS) [3]. Synthesis, secretion and actions of
BDNF are largely mediated by neuronal network activity
and, in turn, activity-dependent secretion of BDNF can
induce both rapid and long-term changes in synaptic effi-
cacy [3]. In rodents, BDNF has been shown to mediate
higher-order activities, such as learning, memory, and
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behavior [4], and also exerts a neuroprotective role in
either global [5] or focal [6] brain ischemia.
BDNF is detectable in the human blood where serum
concentrations of this protein are more than 100-fold
higher than plasma levels [7, 8]. This difference is due to
the large amount of BDNF stored in platelets that
degranulate during the clotting process [9, 10]. The con-
tribution of the multiple potential cellular sources of BDNF
found in the human plasma remains to be defined. In fact,
in addition to the CNS, BDNF is also synthesized and
secreted by peripheral organs, such as vascular endothelia
and visceral epithelia [11, 12]. Importantly, BDNF crosses
the blood-brain barrier by a high-capacity, saturable
transport system [13], and, in rodents, a positive correlation
has been reported between serum and cerebral cortex
BDNF levels [14]. In line with these results, physical
activity, known to increase BDNF levels in the rodent brain
[15, 16], was also shown to increase BDNF blood con-
centrations in humans, and this was accompanied by an
improvement in cognitive function [17]. On the other hand,
decreased plasma and serum BDNF levels were reported in
patients with major depressive disorders [18–20], a
pathology associated with impaired BDNF signaling in the
CNS [21].
Anesthetics are known to cause profound depression of
neuronal activity and the important role of activity-
dependent rapid release of BDNF from its intracellular
stores in order to promote appropriate neuronal network
function is now well established [22, 23]. Recent results
indicate that anesthesia might modulate BDNF levels in the
rodent brain [24]. Theoretically, based on the positive
correlation between brain and blood levels of BDNF, serial
measurements of BDNF blood concentrations may inform
about the temporal evolution pattern of this protein in the
CNS during the perioperative period. This may allow
comparing the influence of different anesthesia protocols as
well as to evaluate the impact of the perioperative stress
response on BDNF kinetics. Information obtained from
such studies would provide further hints on the complex
role of anesthetics on neural network function and might
enable to determine whether this neurotrophic factor could
be used as a surrogate to monitor brain function in surgical
patients. To answer these questions, we need to know first
if, and to what extent, anesthesia and/or surgery are influ-
encing the temporal evolution pattern of BDNF blood
concentrations in the perioperative period.
Hence, the goal of the present study was to evaluate
perioperative BNDF plasma concentrations in a well-con-
trolled surgical setting. Since BDNF plasma levels have
been shown to be dependent on gender, age and body
weight [7], we focused on males, 30–65 years of age, and
with a body mass index of 20–30. We also investigated
whether two frequently used general anesthesia techniques,
i.e. a total intravenous anesthesia using propofol versus a
general anesthetic using thiopental for induction and iso-
flurane for maintenance, modify differently intra- and
postoperative BDNF kinetics.
Materials and Methods
Inclusion and Non-inclusion Criteria
This study was approved by the ethics committee of Uni-
versity Hospitals of Geneva and was conducted from
November 2005 to December 2006. Prior to enrollment,
participating subjects gave written informed consent. All
patients underwent elective lumbar or cervical discal hernia
repair, scheduled to last 1–3 h. We considered these pro-
cedures as minor surgery, without significant hemorrhagic
risk, and minimal perioperative stress response. Patients
with underlying organ and known psychiatric illnesses as
well as those taking steroids and anti-depressants were not
considered.
Anesthesia
Patients received 7.5 mg midazolam orally 30 min prior to
anesthesia. Standard monitoring included three-lead ECG,
non-invasive blood pressure, end-tidal CO2, and peripheral
capillary oxygen saturation. Electrodes for Bispectral Index
(BIS), standardized EEG monitoring which estimate the
depth of anesthesia, were placed on the forehead as rec-
ommended by the manufacturer. BIS values between 40
and 60 are considered as adequate depth of anesthesia.
Upon arrival in the operating room, an 18G catheter was
placed intravenously on the back of a hand and 10 ml of
blood were drawn for baseline measurements of BDNF
plasma concentrations. Anesthesia was then induced using
the same peripheral catheter. Once the patient was anes-
thetized, a second intravenous catheter was placed on the
back of the contra-lateral hand and was subsequently used
for fluid and anesthesia management. All blood samples
were drawn through the first catheter.
Patients were randomly allocated using opaque envelops
to one of two groups. In the propofol group, anesthesia was
induced and maintained with propofol using a target con-
trol infusion system (Base Primea, Fresenius-Vial, Brezins,
France) and the pharmacokinetic model of Schnider et al.
[25]. In the thiopental–isoflurane group, anesthesia was
induced using 5 mg kg-1 thiopental followed by isoflu-
rane. All patients received sufentanil 0.3 lg kg-1
intravenously before endotracheal intubation followed by
an intravenous infusion of 0.2 lg kg-1 h-1 throughout
surgery. Endotracheal intubation was facilitated using a
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single dose of rocuronium 0.6 mg kg-1. Patients were
normo-ventilated with an oxygen-air mixture (FiO2 40%).
Bispectral Index was maintained between 40 and 60
throughout surgery using incremental concentrations of
propofol or isoflurane.
In the recovery room and on the ward, patients received
acetaminophen, non-steroidal anti-inflammatory drugs and
morphine on request to treat postoperative pain.
Measurements
Five venous blood samples (10 ml each) were obtained
from each patient during the study period, i.e. (i) before
induction (baseline), (ii) 15 min following induction, but
before start of surgery, (iii) at skin closure, (iv) in the post-
anesthetic care unit (2 h after the end of surgery), and (v)
24 h postoperatively. Blood samples were drawn into
heparinized containers and put immediately on ice until
processing. Plasma was obtained by centrifugation of the
heparinized containers for 15 min at 2,000g at 4C.
Supernatants were aliquoted and stored at -80C until
measured. BDNF plasma concentrations, using non-diluted
plasma samples, were measured using commercial
enzyme-linked immunosorbent assays (ELISA) according
to the manufacturer’s instructions (Quantikine Human
BDNF Immunoassay, R&D Systems, Minneapolis, USA).
Using this assay, the minimum detectable dose of BDNF is
typically less than 20 pg ml-1.
Statistical Analysis
To compare BDNF values among the two anesthesia
techniques, we used the non-parametric Mann–Whitney U-
test. For comparison of BDNF values within each group,
the two-way ANOVA on log-transformed BDNF values
followed by the Bonferroni test was applied. Correlations
were estimated using the Spearman’s correlation coeffi-
cient. A P-value \ 0.05 was regarded as statistically
significant. Logistic regression was used to test for poten-
tial relationships between different factors (for instance,
duration of surgery) and BDNF plasma concentrations. All
data were analyzed using GraphPad Prism software
(GraphPad Software Inc., San Diego, CA, USA).
Results
Thirty patients, 15 in each group, were randomized. Due to
technical problems during blood processing, data from 4
patients (2 from each group) had to be excluded. Charac-
teristics of the remaining 26 patients were comparable
between the two groups (Table 1). As these procedures can
all be classified as minimal invasive surgery, there were no
relevant blood losses in any patient.
At baseline, BDNF plasma concentrations were
631 ± 337 (mean ± SD) pg ml-1 in the propofol group
and were 549 ± 512 pg ml-1 in the thiopental–isoflurane
group (P = 0.31) (Fig. 1; Tables 2 and 3). At 15 min,
BDNF plasma concentrations were significantly decreased
in the propofol group (247 ± 219 pg ml-1, P = 0.0012
compared with baseline) but remained unchanged in the
thiopental–isoflurane group (597 ± 471 pg ml-1, P =
0.798 compared with baseline) (Figs. 1 and 2). At this time
point, the difference in BDNF values between groups was
statistically significant (P = 0.0012).
At skin closure and in the post-anesthetic care unit,
BDNF plasma concentrations were not different from
baseline in both groups, and there were no differences
between groups (Fig. 1; Tables 2 and 3). At this time point,
the variability in BDNF plasma concentrations was maxi-
mal; in the propofol group, values ranged from 84 to
almost 12,000 pg ml-1; in the thiopental–isoflurane group,
they ranged from 22 to more than 2,500 pg ml-1.
At 24 h, BDNF plasma concentrations decreased below
baseline in both groups (Fig. 1; Tables 2 and 3). In the two
groups, the difference between baseline and the 24 h value
reached statistical significance (propofol: P = 0.0015;
thiopental–isoflurane: P = 0.016).
Since wide variations in BDNF plasma concentrations
were observed at each time point, we evaluated potential
sources of this variability. We tested correlations between
BDNF values and patient characteristics (age, weight,
height, body mass index). This was done with BDNF val-
ues at each time point and for both anesthesia groups
separately. There was no evidence of any correlation
between BDNF plasma concentrations and the tested
parameters at any time point.
Table 1 Demographic and clinical characteristics of patients
Anesthesia procedure P-value
Propofol Thiopental/
isoflurane
n 13 13
Age (years) 48.8 ± 9.5 48.2 ± 7.7 0.98
Weight (kg) 85.2 ± 10.1 79.5 ± 7.7 0.15
Height (cm) 176.5 ± 7.8 176.3 ± 8.3 0.8
BMI 27.1 ± 3.5 25.6 ± 2.1 0.13
Duration of surgery (min) 98 ± 32 88 ± 54 0.23
Pathology
Lumbar discus hernia 10 9
Cervival discus hernia 3 4
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Duration of surgery varied between 60 and 180 min in
the propofol group and between 30 and 240 min in the
thiopental–isoflurane group. In the propofol group, there
was some evidence of a weak, but statistically significant
positive correlation between the duration of surgery and
BDNF values at skin closure (R2 = 0.38, P = 0.026;
Fig. 3a). No such correlation could be found in the thio-
pental–isoflurane group at skin closure (R2 = 0.001,
P = 0.923; Fig. 3b). There was no correlation either
between the duration of surgery and BDNF plasma con-
centrations at subsequent time points (i.e. in the post-
anesthetic care unit or at 24 h postoperatively).
Discussion
Three main results are emerging from this study. First, in
males undergoing elective minor surgery, pre-, intra- and
postoperative BDNF plasma kinetics follow a specific
pattern. Second, BDNF plasma kinetics are influenced by
anesthetic drugs and, possibly, by the duration of surgery.
Third, even in a homogenous cohort and a well-controlled
clinical setting, BDNF plasma concentrations show large
variability.
We focused on plasma BDNF concentrations. In the
human blood, average BDNF levels are about 100-fold
higher in the serum than in the plasma [7, 8]. This differ-
ence is due to the large amount of BDNF that is stored in
circulating platelets that degranulate during the clotting
process when obtaining serum [9, 10]. Given that BDNF
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Fig. 1 Changes in BDNF plasma concentrations during the periop-
erative period in patients who where randomized to one of two groups
(13 patients each): propofol induction and maintenance (a) or to
thiopental induction and isoflurane maintenance (b). T1 = before
induction (baseline); T2 = 15 min following induction but before
initiation of surgery; T3 = skin closure; T4 = post-anesthetic care
unit (2 h after the end of surgery); T5 = 24 h postoperatively. The
top, bottom and line through the middle of the boxplots correspond to
the 75th percentile (top quartile), 25th percentile (bottom quartile),
and 50th percentile (median) respectively. The whiskers on the
bottom extend from the 10th percentile and on the top from the 90th
percentile
Table 2 Temporal evolution pattern of BDNF plasma levels during
the perioperative period in patients receiving propofol anesthesia
Propofol (n = 13) T1 T2 T3 T4 T5
Mean 631 247 1747 645 233
Median 610 232 520 494 229
Std. deviation 337 219 3268 509 129
Minimum 221 20 84 123 30
Maximum 1164 893 11865 1706 413
Table 3 Temporal evolution pattern of BDNF plasma levels during
the perioperative period in patients receiving thiopental/isoflurane
anesthesia
Thiopental/isoflurane (n = 13) T1 T2 T3 T4 T5
Mean 549 597 780 708 253
Median 353 466 549 508 179
Std. deviation 512 471 774 701 250
Minimum 132 296 22 187 39
Maximum 2110 1991 2546 2912 973
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BFig. 2 Short-term evolution of
BDNF plasma levels in patients
receiving either propofol (a) or
thiopental/isoflurane (b)
anesthesia. T1 = baseline
(before induction);
T2 = 15 min following
anesthesia induction
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secreted by the human brain rapidly crosses the blood-brain
barrier [13], we believe that the small amount of BDNF
that is detected in the plasma reflects more reliably, at least
in theory, acute changes of BDNF secretion in the brain.
However, as BDNF is also produced and secreted by non-
neuronal cell types [11, 12], it cannot be excluded that the
observed changes in BDNF plasma concentrations reflect
secretion of this protein from extracerebral sources.
Finally, despite the lack of experimental evidence, effects
of anesthetics on BDNF uptake and release by platelets
cannot be ruled out.
We observed a large variability in BDNF plasma con-
centrations throughout the study period. At the end of
surgery, for instance, when the variability was maximal,
interindividual plasma concentrations varied by a factor of
more than 100. Important interindividual variability of
BDNF plasma concentrations has been described before [8,
26], and subjects’ age, weight and gender have been shown
to have an impact on this variability [7]. We were unable to
identify patients’ characteristics that explained this vari-
ability. This may have been due to the careful selection of a
homogenous, normal-weight, male cohort. However, there
was evidence of a statistically significant, albeit weak,
positive correlation between the duration of the surgical
procedure and BDNF plasma concentrations. This corre-
lation was not fully convincing, since the correlation
coefficient was low, the correlation was statistically sig-
nificant only in patients receiving propofol but not in those
receiving thiopental–isoflurane, and at skin closure only
but not thereafter. However, it is plausible that longer
surgical procedures induce a more pronounced stress
response, and, subsequently, higher BDNF plasma con-
centrations through an increased synthesis of BDNF, a shift
of BDNF from the central to the peripheral compartment, a
combination of both, or yet another, not yet known
mechanism. Finally, it cannot be excluded that the higher
BDNF plasma concentrations in patients undergoing longer
procedures were related to the prolonged administration of
the anesthetic drugs.
We have chosen the time point immediately before
induction to measure baseline BDNF plasma concentrations.
There were no differences in baseline concentrations
between groups. However, average baseline values appeared
to be higher compared with data from healthy volunteers in
previous reports [7, 8, 26]. There are several possible
explanations for this discrepancy. First, although patients in
our study were premedicated with a benzodiazepine, it
cannot be excluded that in some, preoperative anxiety and
stress levels were still significant. In experimental models,
acute stress has been shown to result in a rapid upregulation
of BDNF mRNA and protein levels in the hypothalamo–
hypophyseal stress axis [27], and in the hippocampus [28].
Second, some of the patients may have suffered preopera-
tively from radicular pain, and this may explain higher
baseline BDNF values. However, in one experimental study,
chronic pain appeared to reduce, rather than to increase,
cerebral BDNF levels [29]. Third, baseline measurements
were taken immediately after insertion of a peripheral
venous catheter. This procedure can be painful in some
patients; in one randomized trial, for instance, 20% of
patients reported a pain intensity of 5 or more on a 10-point
scale when a 18G catheter was inserted on the back of a hand
and without a local anesthetic [30]. Whether BDNF plasma
concentrations are changing within seconds after a painful
stimulus remains to be determined. Finally, it cannot be
excluded that technical issues in blood sampling and mea-
surements, for instance, the use of different ELISA kits,
account for the differences between our data and previous
observations.
Perhaps the most striking observation was the decrease
in BDNF plasma concentrations in the propofol group at
15 min. At this time point, patients were exposed to gen-
eral anesthesia only; surgery has not yet commenced. The
study was well controlled; except for induction and main-
tenance agents, patients received identical pharmacological
treatments. Due care was taken to maintain Bispectral
Index within a narrow range. Thus, we may assume that
the decrease in BDNF plasma concentrations in the pro-
pofol group at 15 min was directly related to the
administration of propofol, or the absence of thiopental–
isoflurane, or both. Anesthetics are known to cause pro-
found depression of neuronal activity; the important role of
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activity-dependent rapid release of BDNF from its intra-
cellular stores in order to promote appropriate neuronal
network function has been described [22, 23]. Propofol
may influence BDNF secretion in the CNS through
GABAA-independent mechanisms. Alternatively, propofol
may interfere with the rate of BDNF uptake or release by
platelets and the impact of propofol on non-neural BDNF
secretion from peripheral organs cannot be excluded either.
While propofol, thiopental and isoflurane all enhance
inhibitory GABAergic neurotransmission [31], differences
in pharmacokinetic and dynamic exist between these drugs
and these differences may also explain, at least in part,
differences in BDNF plasma concentrations after 15 min.
Clearly, further laboratory and clinical research is needed
to answer these questions.
Between the 15th minute and skin closure, no further
measurements were performed. Thus, we do not know
whether BDNF plasma concentrations in the propofol
group would have decreased further and at what time point
they were eventually back to baseline values.
Twenty-four hours after surgery, we found a significant
decrease in plasma BDNF concentrations compared with
baseline in both groups. This suggests that in our study
population, stress levels, or other mechanisms that increase
BDNF levels, were lower at 24 h after surgery than
immediately before induction of anesthesia. Our last
measurement was at 24 h. We cannot exclude that sub-
sequent measurements would have shown even lower
plasma concentrations. Low plasma BDNF concentrations
in the postoperative period may reflect anesthesia-related
long-term changes in the production of this protein. It has
been shown that general anesthesia can induce persistent
changes in gene expression in the CNS [32]. It remains to
be shown, whether exposure to anesthesia induces long-
term changes in BDNF expression. Alternatively,
decreased plasma BDNF values could reflect the long-term
effects of anesthesia on vascular endothelia, peripheral
organs and on platelet function.
Our study has limitations and the results are raising
important questions that may inform the research agenda.
We included a limited number of well-selected, males
undergoing one type of minor surgery. Future investiga-
tions may focus on larger and more heterogeneous
cohorts that allow for appropriate subgroup analyses, to
study, for instance, the impact of gender or of different
surgical settings on BDNF kinetics. More work is
required to investigate BDNF plasma kinetics in patients
undergoing major surgery. Our time window may have
been too narrow to adequately document perioperative
BDNF kinetics. To obtain an adequate baseline, the first
measurement should be done longer before surgery,
perhaps in ambulatory patients who are not yet submitted
to pre-surgical anxiety and stress. The last measurement
needs to be taken longer after the end of surgery to
ensure complete recording of BDNF kinetics. The dif-
ferential effect of propofol and thiopental–isoflurane on
BDNF kinetics needs to be elucidated. Also, whether
changes in plasma BDNF concentrations reflect altered
BDNF secretion in the CNS or other mechanisms
remains to be determined. Finally, given the important
role of BDNF in higher order cognitive functions [4], the
possibility of an association between low BDNF plasma
levels and the extent of postoperative cognitive deficits
should be evaluated.
In conclusion, in healthy males undergoing elective
minor surgery, pre-, intra- and postoperative BDNF plasma
concentrations follow a specific pattern. In the early period
of propofol anesthesia, and in the absence of surgery,
BDNF plasma concentrations are significantly decreased.
Reasons for this decrease remain unknown. The large
variability in plasma concentrations throughout the peri-
operative period precludes prediction of BDNF values in
individual patients. Future studies should elucidate reasons
for this variability.
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